EGFR and non-small cell lung carcinoma: Yousefi and colleagues investigated whether imaging features of tumors from patients with metastatic NSCLC can be combined with ctDNA data to improve the prediction of survival after epidermal growth factor receptor (EGFR)-targeted therapy [36].